###begin article-title 0
IL-10 Is Critically Involved in Mycobacterial HSP70 Induced Suppression of Proteoglycan-Induced Arthritis
###end article-title 0
###begin p 1
Conceived and designed the experiments: LW SEB RvdZ FB WvE. Performed the experiments: LW SEB CBtB PJvK FB. Analyzed the data: LW SEB RvdZ FB WvE. Contributed reagents/materials/analysis tools: MS TTG. Wrote the paper: LW SEB RvdZ FB WvE.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 413 419 <span type="species:ncbi:10090">murine</span>
The anti-inflammatory capacity of heat shock proteins (HSP) has been demonstrated in various animal models of inflammatory diseases and in patients. However, the mechanisms underlying this anti-inflammatory capacity are poorly understood. Therefore, the possible protective potential of HSP70 and its mechanisms were studied in proteoglycan (PG) induced arthritis (PGIA), a chronic and relapsing, T cell mediated murine model of arthritis.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 259 267 255 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 528 536 520 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 606 607 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 611 612 603 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 673 676 665 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
HSP70 immunization, 10 days prior to disease induction with PG, inhibited arthritis both clinically and histologically. In addition, it significantly reduced PG-specific IgG2a but not IgG1 antibody production. Furthermore, IFN-gamma and IL-10 production upon in vitro restimulation with HSP70 was indicative of the induction of an HSP70-specific T cell response in HSP70 immunized mice. Remarkably, HSP70 treatment also modulated the PG-specific T cell response, as shown by the increased production of IL-10 and IFN-gamma upon in vitro PG restimulation. Moreover, it increased IL-10 mRNA expression in CD4+CD25+ cells. HSP70 vaccination did not suppress arthritis in IL-10-/- mice, indicating the crucial role of IL-10 in the protective effect.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
In conclusion, a single mycobacterial HSP70 immunization can suppress inflammation and tissue damage in PGIA and results in an enhanced regulatory response as shown by the antigen-specific IL-10 production. Moreover, HSP70 induced protection is critically IL-10 dependent.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 365 368 365 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-vanEden1">[1]</xref>
###xml 369 372 369 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-vanPuijvelde1">[4]</xref>
Heat shock proteins (HSP) are highly immunogenic and have the potential to trigger immuno-regulatory pathways. Although the exact mechanisms of immuno-regulation by HSP remain to be clarified, T cells specific for HSP were suggested to be involved in regulation of multiple chronic inflammatory diseases like rheumatoid arthritis (RA), diabetes and atherosclerosis [1]-[4].
###end p 9
###begin p 10
###xml 164 167 164 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-deKleer1">[5]</xref>
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Kamphuis1">[6]</xref>
###xml 554 557 554 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Prakken1">[7]</xref>
###xml 719 722 719 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-vanderZee1">[8]</xref>
###xml 724 727 724 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Wendling1">[9]</xref>
###xml 856 860 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Tanaka1">[10]</xref>
###xml 997 1001 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Prakken2">[11]</xref>
###xml 1003 1007 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Raz1">[12]</xref>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
###xml 475 479 <span type="species:ncbi:10116">rats</span>
###xml 988 996 <span type="species:ncbi:9606">patients</span>
Recent studies on HSP-responding T cells of juvenile idiopathic patients implied a regulatory role and contribution to disease remission for HSP60-specific T cells [5], [6]. Among the various HSP families of molecules, the immuno-modulatory potential of HSP60 has been studied most extensively. However, also other HSP have immuno-regulatory functions. For example treatment with bacterial HSP70 has been shown to protect against development of adjuvant induced arthritis in rats, whereas treatment with other highly conserved bacterial proteins did not [7]. Exposure to bacterial HSP has been shown to activate self HSP-specific T cells that were cross reactive with bacterial HSP and induced suppression of arthritis [8], [9]. In addition, a T cell line specific for an HSP70-derived peptide has been described to decrease disease severity upon transfer [10]. The protective potential of HSP, in animal models, has been reproduced by recent clinical trials with HSP-derived peptides in patients [11], [12].
###end p 10
###begin p 11
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Moore1">[13]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Katsikis1">[15]</xref>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Tang1">[16]</xref>
Even though HSP induced immuno-regulation has been studied rather extensively, the mechanism of HSP induced protection in autoimmune diseases is still not clear. A potential regulatory mechanism might be via the induction of IL-10 since the important role of IL-10 in dampening inflammation has been described extensively [13]-[15]. Additionally, IL-10 requirement for their suppressive function has been thought to be a common feature among most subsets of regulatory T cells as summarized [16].
###end p 11
###begin p 12
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Glant1">[17]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Hanyecz1">[18]</xref>
###xml 250 256 <span type="species:ncbi:10090">murine</span>
###xml 336 341 <span type="species:ncbi:9606">human</span>
###xml 471 474 <span type="species:ncbi:31658">CFA</span>
###xml 586 589 <span type="species:ncbi:31658">CFA</span>
###xml 968 972 <span type="species:ncbi:10090">mice</span>
In the present study the protective potential of mycobacterial HSP70 immunization on inflammatory disease and its dependency on IL-10 were assessed in the proteoglycan-induced arthritis model (PGIA), a progressive T cell dependent, antibody-mediated murine model for RA [17]. In this model arthritis can be induced by immunization with human proteoglycan (PG) mixed with synthetic adjuvant dimethyldioctadecylammonium bromide (DDA) instead of complete Freund's adjuvant (CFA) [18]. Therefore, the possibility of interfering with immune responses induced by mycobacterial HSP present in CFA can be excluded. We found that HSP70 immunization dramatically suppressed arthritis development, subsequent tissue damage and the pathogenic PG-specific antibody response. Moreover, we demonstrate that HSP70 immunization results in a regulatory T cell response not only to HSP70, but also to the disease inducing PG. Finally, HSP70 did not suppress arthritis in IL-10 deficient mice, indicating that the regulatory response is IL-10 dependent.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin title 14
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 14
###begin p 15
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Kuhn1">[19]</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Female BALB/c mice, retired breeders aged between 16-26 weeks, purchased from Charles River (Maastricht, The Netherlands), and IL-10-/- mice also on the BALB/c background (kindly provided by Dr. D. Reddick, DNAX, Palo Alto, CA) [19] were bred, housed and fed under standard conditions. Experiments were approved by the Animal Experiment Committee of Utrecht University (Utrecht, the Netherlands).
###end p 15
###begin title 16
Induction and assessment of arthritis
###end title 16
###begin p 17
###xml 82 86 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Glant1">[17]</xref>
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Hanyecz1">[18]</xref>
###xml 312 316 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Berlo1">[20]</xref>
###xml 594 598 586 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Hanyecz1">[18]</xref>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
Arthritis was induced with PG using a standard immunization protocol as described [17], [18]. Briefly, 300 microg PG protein was given by intra peritoneal injection (i.p) with 2 mg of DDA (Sigma, Zwijndrecht, the Netherlands) emulsified in 200 microl PBS on days 0 and 21. PG was prepared as described elsewhere [20]. After the second PG immunization the paws of mice were examined in a blinded fashion 3 times a week to record arthritic changes of the joints. The onset and severity of arthritis were determined using a visual scoring system based on swelling and redness of paws as described [18]. Upon sacrifice, joints were fixed in 10% buffered formalin, decalcified in 0.33 M neutralized EDTA, embedded in paraffin and 5 microm sagittal sections were stained with hematoxylin and eosin.
###end p 17
###begin title 18
HSP70 or control immunization
###end title 18
###begin p 19
###xml 154 180 150 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 154 180 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
HSP70 or control immunization was done, 10 days prior to arthritis induction, by intraperitoneal (i.p.) immunization with 100 microg recombinant HSP70 of Mycobacterium tuberculosis (Mt) (LIONEX Diagnostics&Therapeutics GmbH, Braunschweig, Germany), or 100 microg control protein, either recombinant enhanced green fluorescent protein (EGFP) or ovalbumin (Ova) (Sigma) in adjuvant DDA, 2 mg emulsified in PBS or with PBS in a total volume of 200 microl. To avoid interference of LPS contamination with HSP70 treatment, HSP70 containing less than 2.1 EU/mg protein was used.
###end p 19
###begin title 20
Analysis of PG- and HSP70-specific serum antibody production
###end title 20
###begin p 21
###xml 88 92 88 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Hanyecz1">[18]</xref>
###xml 289 290 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 294 295 286 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 297 298 289 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 893 897 <span type="species:ncbi:10090">mice</span>
Antigen-specific serum antibody levels were determined by ELISA as described previously [18]. In brief, 96 well plates (Corning B.V. Live Sciences, Schiphol Rijk, the Netherlands) were coated by overnight incubation with 100 microl PG or HSP70 at 5 microg/ml in coating buffer (0.1 M NaHCO3, Na2CO3 pH 9.6). Free binding sites were blocked with blocking buffer, Roche blocking reagents for ELISA (Roche Diagnostics, Alkmaar, the Netherlands) followed by incubation with sera at increasing dilutions and subsequently peroxidase-conjugated anti-IgG1, -IgG2a or -total IgG (BD Pharmingen, Breda, the Netherlands) in blocking buffer. After ABTS incubation serum PG-specific antibody levels were calculated as OD relative to the OD measured for the corresponding isotypes of a standard of pooled sera from arthritic mice. For HSP70-specific antibody production a reference serum of HSP70 immunized mice was used. Data were expressed relative to the average of the control group.
###end p 21
###begin title 22
Measurement of antigen-specific T cell responses
###end title 22
###begin p 23
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 417 419 401 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 527 528 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 641 642 621 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1397 1400 1365 1368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
###xml 1401 1405 <span type="species:ncbi:10090">mice</span>
Single-cell suspensions of spleens were cultured in triplicates in 96-well flat bottom plates (Corning B.V.) at 2x105 cells per well, in the presence or absence of HSP70 (10 microg/ml), PG (10 microg/ml) or Ova (10 microg/ml). Iscove's Modified Dulbecco's Medium (IMDM) supplemented with 10% FCS (Bodinco B.V., Alkmaar, the Netherlands), 2 mM L-glutamine, 100 units/ml penicillin, 100 microg/ml streptomycin, and 5x10-5 M 2-mercaptoethanol was used as culture medium. After 72 or 96 hours, the cells were pulsed overnight with 3H-thymidine (0.4 microCi per well; Amersham Biosciences Europe GmbH, Roosendaal, the Netherlands), harvested and 3H uptake was measured by liquid scintillation counting (Microbeta, Perkin-Elmer Inc., Boston, MA). Supernatants of antigen stimulated spleen cell cultures were collected for cytokine assays after 72 hours. Supernatants harvested from cultures with cells isolated from WT mice were analyzed for IL-10 and interferon-gamma (IFN-gamma) expression simultaneously by multiplex analysis using the Luminex 100 system (Becton Dickinson, Mountain View, CA). The LINCOplex assay was performed according to the manufacturer's instructions (Linco Research, Inc., St. Charles, Missouri). The concentrations of IL-10 and IFN-gamma in the supernatants were calculated using LMAT software (Luminex Corporation, Austin, TX). IFN-gamma secretion by cells isolated from IL10-/- mice was measured by ELISA (BD OptEIA) according to manufactures protocol (BD Pharmingen).
###end p 23
###begin title 24
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Assessment of IL-10 and Foxp3 mRNA expression, in CD4+CD25+ spleen cells
###end title 24
###begin p 25
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 21 22 21 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 234 235 234 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 948 980 906 938 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGT TGC CAA GCC TTA TCG GA-3&#8242;</named-content>
###xml 985 1017 943 975 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACC TGC TCC ACT GCC TTG CT-3&#8242;</named-content>
###xml 1027 1058 985 1016 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CCC AGG AAA GAC AGC AAC CTT</named-content>
###xml 1063 1095 1021 1053 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTC TCA CAA CCA GGC CAC TTG-3</named-content>
###xml 1157 1186 1115 1144 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTG GTG AAA AGG ACC TCT CG</named-content>
###xml 1191 1231 1149 1189 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGA AGT ACT CAT TAT AGT CAA GGG CA-3&#8242;</named-content>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Isolation of CD4+CD25+ spleen cells from arthritic mice was done by staining single cell suspensions of spleen cells with anti-CD4-allophycocyanin (RM4-5) and anti-CD25 r-phycoerythrin (PC61) monoclonal antibodies (BD Pharmingen). CD4+CD25+ cells were sorted by CD4 and CD25 expression with a FACSVantage SE (Becton Dickinson). Then total mRNA extraction, with the RNeasy kit (Qiagen Benelux B.V., Venlo, the Netherlands), on column DNAse treatment (Qiagen), and transcription into cDNA using the iScripttrade mark cDNA Synthesis Kit (Bio-Rad Laboratries B.V., Veenendaal, The Netherlands) were carried out according to manufacturers protocol. PCR (3 min at 95degreesC and 40 cycles of 10 s 95degreesC and 45 s at 59.5degreesC) and Real-Time detection were performed in a Bio-Rad MyiQ iCycler (Bio-Rad). Amplification was done using IQtrade mark SYBR Green(R) Supermix (Bio-Rad) with 0.25 microM final concentrations of primers specific for IL-10 (5'-GGT TGC CAA GCC TTA TCG GA-3' and 5'-ACC TGC TCC ACT GCC TTG CT-3'), Foxp3 (5'- CCC AGG AAA GAC AGC AAC CTT and 5'-TTC TCA CAA CCA GGC CAC TTG-3) and hypoxanthine-guanine phosphoribosyl transferase (HPRT) (5'-CTG GTG AAA AGG ACC TCT CG and 5'-TGA AGT ACT CAT TAT AGT CAA GGG CA-3'). For each sample mRNA expression was normalized to the detected Ct value of HPRT and expressed relative to the average of the control group.
###end p 25
###begin title 26
Statistical analysis
###end title 26
###begin p 27
Unless stated otherwise, data are expressed as mean+/-standard error of the mean (SEM). Statistical analysis was carried out using the Mann-Whitney U test (two-tailed) using Prism software (version 3.00, Graphpad Software Inc., San Diego). Significance level was set at (p<0.05).
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
Immunization with HSP70 decreases arthritis incidence and severity
###end title 29
###begin p 30
###xml 672 679 658 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g001">Fig. 1A</xref>
###xml 751 758 737 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g001">Fig. 1B</xref>
###xml 1026 1035 1012 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g002">Fig. 2A&#8211;B</xref>
###xml 151 155 <span type="species:ncbi:10090">Mice</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
To investigate the immuno-regulatory mechanisms of HSP70 in inflammatory diseases, the effect of mycobacterial HSP70 immunization in PGIA was studied. Mice were treated with HSP70 10 days prior to induction of arthritis by i.p. immunization with 100 microg HSP70, in the synthetic adjuvant DDA, whereas control groups received 100 microg EGFP or PBS in DDA. Subsequently, arthritis was induced by two i.p. immunizations with PG in DDA on day 0 and 21. HSP70 immunization lowered the incidence of arthritis and significantly delayed the onset of arthritis; day 52+/-3.2 in HSP70 immunized mice compared to day 31+/-2.0 in EGFP and 30+/-1.0 in PBS pretreated mice (p<0.01) (Fig. 1A). Furthermore, HSP70 pre-treatment evidently reduced severity of PGIA (Fig. 1B). In association, histological analysis of joint sections of HSP70 immunized arthritic mice showed very mild leukocyte infiltration, less reactive synovial cell proliferation, and consequently almost no cartilage damage compared to joint sections of control animals (Fig. 2A-B).
###end p 30
###begin title 31
Decreased arthritis incidence and severity after HSP70 immunization.
###end title 31
###begin p 32
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
Mice were injected intraperitoneally, 10 days prior to disease induction, with either 100 microg recombinant microbial heat shock protein 70 (HSP70) or 100 microg enhanced green fluorescent protein (EGFP) both emulsified in synthetic adjuvant DDA or with PBS. Arthritis was induced by two immunizations of proteoglycan (PG) in DDA on day 0 and 21. (A) Arthritis incidence is expressed as the cumulative percentage of arthritic animals and (B) arthritis severity is expressed as the mean arthritis score of sick mice+/-SEM. Data are representative of three independent experiments (n = 10 in each group).
###end p 32
###begin title 33
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Decreased leukocyte infiltration and cartilage breakdown in HSP70 immunized mice.
###end title 33
###begin p 34
###xml 118 126 118 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g001">figure 1</xref>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
PBS or heat shock protein 70 (HSP70)/DDA immunization, followed by arthritis induction, was performed as described in figure 1. Upon sacrifice on day 35, histology of tarso-metatarsal joints was done by staining of the sections with hematoxylin and eosin. (A) Synovial hyperplasia with infiltrating leukocytes, cartilage- (arrow heads) and bone-erosions (arrows) can be seen. (B) In contrast, only a very few leukocytes, and no synovial cell proliferation or cartilage destruction were observed in the joint sections of HSP70 immunized mice.
###end p 34
###begin title 35
Altered antigen-specific B cell responses after HSP70 immunization
###end title 35
###begin p 36
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Glant1">[17]</xref>
###xml 518 525 518 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g003">Fig. 3A</xref>
###xml 821 828 821 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g003">Fig. 3B</xref>
###xml 1107 1111 1107 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Kim1">[21]</xref>
###xml 1113 1117 1113 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Ulmansky1">[22]</xref>
###xml 1372 1379 1372 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g003">Fig. 3C</xref>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
###xml 1366 1370 <span type="species:ncbi:10090">mice</span>
PG-specific B cell responses have been described to be required for development of severe PGIA [17]. Therefore, the PG-specific B cell response and the effect of HSP70 immunization on this response were studied. On day 38 after the first PG injection PG-specific serum IgG1 and IgG2a levels were determined by ELISA. High IgG1 levels confirmed the induction of a B cell response against the disease inducing PG in both treatment groups. However, the level of IgG2a was lowered in HSP70 compared to PBS immunized mice (Fig. 3A). In addition, we studied the pattern on days 50-64, after development of mild disease in HSP70 immunized mice. At days 50-64 the difference between PBS and HSP70 immunized mice in IgG1 levels was comparable to day 38 but the decrease in IgG2a, as observed on day 38, was no longer significant (Fig. 3B). The data indicate that mainly the PG-specific IgG2a production was influenced by HSP70 immunization and underline the importance of this isotype for induction of PGIA. Recently, HSP-specific antibodies have been shown to play a role in HSP induced regulation in models for RA [21], [22]. To address whether HSP70-specific antibodies were also induced upon HSP70 immunization in the PGIA model, HSP70 serum antibody levels were analyzed by ELISA. Significantly increased HSP70-specific total IgG production was found in HSP70 immunized mice (Fig. 3C). Thus, both PG- and HSP70-specific B cell responses were altered upon HSP70 treatment as shown by a decreased pathogenic PG-specific response and an increased, possibly protective HSP70-specific B cell response.
###end p 36
###begin title 37
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Altered PG- and HSP70-specific B cell responses in HSP70 immunized mice.
###end title 37
###begin p 38
###xml 96 100 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 664 668 <span type="species:ncbi:10090">mice</span>
Proteoglycan (PG)- or heat shock protein 70 (HSP70)-specific antibody production in the sera of mice was assessed by ELISA and relative serum antibody levels were calculated as OD relative to the OD measured for a standard of pooled sera. (A-B) PG-specific IgG1 and IgG2a levels were determined (A) on day 38 and (B) on day 50 or 64 after disease induction. (C) HSP70-specific total IgG production was measured in sera obtained on day 38. Values in A and C represent the mean+/-SEM (n = 5 mice in each group) and are representative for three independent experiments (PG-specific IgG) or one experiment (HSP70-specific IgG). Values in B represent mean+/-SEM (n = 6 mice) of sera obtained on either day 50 or day 64, no obvious difference between sera collected on day 50 or 64 was detected. Open bars show the PBS immunized group and filled bars the HSP70 immunized group. Significant difference (* p<0.05 or **p<0.01, Mann-Whitney U Test) is indicated by the asterisk.
###end p 38
###begin title 39
Increased antigen-specific proliferation, IL-10 and IFN-gamma production after immunization with HSP70
###end title 39
###begin p 40
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Prakken1">[7]</xref>
###xml 142 145 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Wendling1">[9]</xref>
###xml 605 606 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1005 1012 999 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g004">Fig. 4A</xref>
###xml 1378 1386 1368 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1402 1409 1392 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g004">Fig. 4B</xref>
###xml 1483 1491 1473 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1624 1631 1610 1617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g004">Fig. 4C</xref>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
###xml 999 1003 <span type="species:ncbi:10090">mice</span>
###xml 1342 1346 <span type="species:ncbi:10090">mice</span>
###xml 1604 1608 <span type="species:ncbi:10090">mice</span>
In previous studies, HSP-specific T cell responses have been described to be involved in HSP-induced protection from disease development [7], [9]. To study the effect of HSP70 immunization on differentiation of antigen-specific T cell responses, PG- and HSP70-specific proliferation and cytokine profiles were analyzed. Therefore, spleen cells from HSP70 or PBS immunized mice were harvested on day 35 after the first PG immunization. Antigen-specific proliferation was assessed by culturing the isolated cells for 96 hours with PG or HSP70 while Ova was used as control antigen. During the last 18 hours 3H-thymidine was added and incorporation was measured and expressed as mean stimulation index (CPM Antigen/CPM background)+/-SEM. The mean background values (responses without antigen) were for the PBS control group 8390+/-2135 and for the HSP70 group 10 180+/-2741. A significantly enhanced proliferative response to HSP70 restimulation was seen in HSP70 immunized mice as compared to control mice (Fig. 4A). Remarkably, also the proliferative response against the arthritis inducing PG was enhanced in the HSP70 group. Next, antigen-induced production of IL-10 and IFN-gamma was studied in supernatants collected after 72 hours culturing in the presence of PG or HSP70. Increased IL-10 production, by spleen cells from HSP70 immunized mice, could be detected after HSP70 in vitro restimulation (Fig. 4B). Interestingly, this increased IL-10 production was also found after PG in vitro restimulation. Furthermore, the amount of IFN-gamma produced by HSP70- and PG-specific cells from HSP70 treated mice was increased (Fig. 4C). In summary this clearly showed that HSP70 immunization not only induced an HSP70-specific T cell response but also modulated the T cell response to the disease inducing antigen.
###end p 40
###begin title 41
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Augmented antigen-specific proliferation, IL-10 and IFN-gamma production in HSP70 immunized mice.
###end title 41
###begin p 42
###xml 104 112 104 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g001">figure 1</xref>
###xml 169 170 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 357 358 353 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 606 614 596 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were immunized with PBS or heat shock protein 70 (HSP70) and arthritis was induced as described in figure 1. Spleen cells were isolated on day 35 and cultured (2x105/well) in the presence of recombinant microbial HSP70, proteoglycan (PG) or ovalbumin (Ova) (all at 10 microg/ml). (A) After 96 hours incubation proliferation was determined by measuring 3H incorporation. Results are expressed as mean stimulation index (CPM Antigen/CPM background)+/-SEM. The mean background values (responses without antigen) were for the PBS control group 8390+/-2135 and for the HSP70 group 10 180+/-2741. (B-C) For in vitro cytokine secretion the spleen cells were cultured in the presence of antigen. After 72 hours supernatants were harvested and assayed by multiplex analysis for IL-10 and IFN-gamma excretion. Open bars show the PBS immunized group and filled bars the HSP70 immunized group. Values represent the mean+/-SEM of cytokine levels. Significant difference (p<0.05, Mann-Whitney U Test) is indicated by the asterisk. Data are representative for at least two independent experiments.
###end p 42
###begin title 43
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Enhanced IL-10 mRNA expression in CD4+CD25+ T cells after HSP70 immunization
###end title 43
###begin p 44
###xml 174 177 174 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-vanderZee1">[8]</xref>
###xml 179 182 179 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Wendling1">[9]</xref>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 282 283 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 523 524 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 528 529 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 603 609 603 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g005">Fig. 5</xref>
###xml 560 564 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
It has been proposed that induction or activation of HSP70-specifc regulatory T cells cross-reactive with self-HSP70 are involved in protection seen after HSP70 immunization [8], [9]. To study in more detail whether HSP70 immunization influenced natural regulatory T cells, CD4+CD25+ cells were isolated from the spleen on day 38 after the first PG injection. In this population Foxp3 and IL-10 mRNA expression were analyzed by Quantitative Real-Time PCR analysis showing that IL-10 mRNA expression was increased in the CD4+CD25+ population from HSP70 treated mice compared to PBS treated control mice (Fig. 5). No clear difference in Foxp3 mRNA expression was observed, between control and HSP70 immunized mice. This could be confirmed by intracellular staining and flow cytometric analysis of Foxp3 protein expression (data not shown). Indicating that HSP70 does not increase the population of Foxp3 expressing regulatory T cells.
###end p 44
###begin title 45
###xml 38 39 38 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Increased IL-10 mRNA expression in CD4+CD25+ cells of HSP70 immunized mice.
###end title 45
###begin p 46
###xml 103 111 103 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g001">figure 1</xref>
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 132 133 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
Mice were PBS or heat shock protein 70 (HSP70) immunized before induction of arthritis as described in figure 1. On day 38, CD4+CD25+ cells were isolated from the spleen followed by isolation of mRNA. Foxp3 and IL-10 mRNA expression was determined by Quantitative Real-Time PCR analysis. Data are normalized and expressed relative to HPRT and depicted as mean+/-SEM (n = 5 mice in each group). Significant difference (p<0.05, Mann-Whitney U Test) is indicated by the asterisk.
###end p 46
###begin title 47
IL-10 is important for the protective effects of HSP70 immunization
###end title 47
###begin p 48
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 436 439 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 554 557 550 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 677 684 673 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004186-t001">Table 1</xref>
###xml 854 857 850 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1045 1052 1041 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g006">Fig. 6A</xref>
###xml 1130 1133 1126 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1260 1267 1256 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g006">Fig. 6B</xref>
###xml 1368 1371 1364 1367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1503 1511 1499 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1563 1564 1559 1560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1833 1836 1825 1828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2016 2023 2008 2015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g006">Fig. 6C</xref>
###xml 2265 2268 2253 2256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2460 2463 2440 2443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2470 2477 2450 2457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g006">Fig. 6D</xref>
###xml 2543 2546 2523 2526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 471 475 <span type="species:ncbi:10090">mice</span>
###xml 477 479 <span type="species:ncbi:10090">WT</span>
###xml 558 562 <span type="species:ncbi:10090">mice</span>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
###xml 1134 1138 <span type="species:ncbi:10090">mice</span>
###xml 1372 1376 <span type="species:ncbi:10090">mice</span>
###xml 1804 1806 <span type="species:ncbi:10090">WT</span>
###xml 1807 1811 <span type="species:ncbi:10090">mice</span>
###xml 1837 1841 <span type="species:ncbi:10090">mice</span>
###xml 2092 2096 <span type="species:ncbi:10090">mice</span>
###xml 2269 2273 <span type="species:ncbi:10090">mice</span>
###xml 2427 2429 <span type="species:ncbi:10090">WT</span>
###xml 2430 2434 <span type="species:ncbi:10090">mice</span>
###xml 2464 2468 <span type="species:ncbi:10090">mice</span>
###xml 2547 2551 <span type="species:ncbi:10090">mice</span>
HSP70 immunization increased the antigen-specific IL-10 production suggesting that IL-10 is important for the anti-inflammatory capacity of HSP70. To address whether protection in arthritis by HSP70 immunization was indeed IL-10 dependent, IL10-/- mice received 100 microg HSP70 or Ova as control i.p. in DDA on day -10, followed by induction of arthritis by two injections with PG in DDA on day 0 and day 21. HSP70 immunization of IL10-/- mice, in contrast to wild type mice (WT), did not reduce arthritis severity as compared to control, immunized IL10-/- mice. In addition, there was no obvious difference in the mean maximum arthritis score or the day of onset of disease (Table 1). To study the effect of HSP70 immunization, in the absence of IL-10, on the B cell response, PG- and HSP70-specific antibody production was measured in the sera of IL10-/- mice on day 53 after the first PG injection. Induction of arthritis resulted in a clear PG-specific antibody response as shown by elevated IgG1 and IgG2a levels in both treatment groups (Fig. 6A). However, in parallel with the arthritis scores, HSP70 immunization in IL-10-/- mice did not influence this PG-specific response. As expected, HSP70 immunization enhanced the HSP70-specific IgG production (Fig. 6B). Next, induction and modulation of the antigen-specific T cell response by HSP70 treatment in IL-10-/- mice were addressed. Therefore, spleen cells were harvested on day 53 followed by analysis of antigen-specific proliferation after in vitro restimulation, for 72 hours with PG, Ova or HSP70. 3H incorporation was depicted as stimulation index (CPM antigen/CPM background). The mean background values (responses without antigen) were for the PBS control group 1705+/-339 and for the HSP70 group 1394+/-468. Similar to the response in WT mice, immunization of IL10-/- mice with HSP70 enhanced the proliferative response to HSP70 restimulation compared to control immunization with Ova. But, it did not have an effect on PG-specific proliferation (Fig. 6C). Furthermore, Ova specific proliferation was slightly increased in mice that received Ova. In addition, the effect of HSP70 immunization on antigen-specific IFN-gamma secretion was studied, by ELISA in the culture supernatants. Also in IL10-/- mice, immunization with HSP70 increased the production of IFN-gamma after HSP70 restimulation. But, the enhanced PG-induced IFN-gamma production, observed in WT mice, was not observed in IL10-/- mice (Fig. 6D). Taken together, this indicated that HSP70 immunization of IL-10-/- mice induced an HSP70-specific B and T cell response that, in the absence of IL-10, failed to suppress PGIA development and PG-specific pathogenic IgG2a production.
###end p 48
###begin title 49
Protective effects found upon HSP70 immunization are IL-10 dependent.
###end title 49
###begin p 50
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 145 153 145 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004186-g001">figure 1</xref>
###xml 625 626 625 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 996 1000 <span type="species:ncbi:10090">mice</span>
IL10-/- mice were immunized with ovalbumin (Ova) or heat shock protein 70 (HSP70), subsequently arthritis was induced and scored as described in figure 1. (A) Proteoglycan (PG)-specific IgG1 and IgG2a and (B) HSP70-specific total IgG production was measured by ELISA in sera obtained on day 52. Data in A and B are depicted relative to a standard of pooled sera from either arthritic mice or HSP70 immunized mice. (C) Antigen-specific proliferation of spleen cells harvested on day 52 was measured after 72 hours culturing in the presence of recombinant microbial HSP70, Ova or PG. Proliferation was measured by detection of 3H incorporation and depicted as stimulation index (CPM Antigen/CPM background). The mean background values (responses without antigen) were for the PBS control group 1705+/-339 and for the HSP70 group 1394+/-468. (D) After 72 hours incubation, antigen-induced IFN-gamma excretion in the culture supernatants was analyzed by ELISA. Values represent the mean+/-SEM (n = 5 mice in each group). Open bars show the Ova immunized group and filled bars the HSP70 immunized group. Significant difference (p<0.05, Mann-Whitney U Test) is indicated by the asterisk.
###end p 50
###begin title 51
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 49 51 <span type="species:ncbi:10090">WT</span>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Mean day of onset and maximum arthritis score in WT and IL10-/- mice.
###end title 51
###begin p 52
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 25 27 <span type="species:ncbi:10090">WT</span>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 533 535 <span type="species:ncbi:10090">WT</span>
###xml 536 540 <span type="species:ncbi:10090">mice</span>
###xml 561 563 <span type="species:ncbi:10090">WT</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
Arthritis was induced in WT BALB/c (n = 10 per group) or IL-10-/- mice (n = 5 per group) by two immunizations with proteoglycan in the adjuvant DDA on days 0 and day 21. Ten days prior to the induction of arthritis mice were immunized with 100 microg HSP70 whereas control mice received 100 microg EGFP or Ova. Subsequently, development of arthritis symptoms was scored by clinical examination. Data are expressed as mean+/-SEM and are representative for at least two independent experiments. * p<0.05 and ** p<0.01 (HSP70 immunized WT mice compared to control WT mice by Mann Whitney U test).
###end p 52
###begin title 53
Discussion
###end title 53
###begin p 54
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-vanEden1">[1]</xref>
###xml 155 158 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-deKleer1">[5]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Prakken2">[11]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Raz1">[12]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Albani1">[23]</xref>
###xml 178 182 178 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-VanEden1">[24]</xref>
###xml 104 112 <span type="species:ncbi:9606">patients</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
The anti-inflammatory properties of HSP have been shown in several studies in both animal models and in patients suffering from inflammatory diseases [1], [5], [11], [12], [23], [24]. However, for further development of HSP for therapeutic application, it is essential to understand the mechanisms by which HSP affect chronic inflammatory disease in more detail. In this study we analyzed the protective potential of HSP70 in PGIA, a chronic model for RA, studied the T cell response induced by HSP70 immunization and addressed whether the presence of IL-10 was essential. Our data clearly show that pretreatment with HSP70 delayed arthritis onset and dramatically reduced disease severity both clinically and histologically. Furthermore, it increased the antigen-specific T cell response to both the protective HSP70 and the disease inducing PG. In IL-10 deficient mice HSP70 immunization did not suppress arthritis illustrating the IL-10 dependency of HSP70 induced immuno-regulation.
###end p 54
###begin p 55
###xml 109 112 109 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Wendling1">[9]</xref>
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Kingston1">[25]</xref>
###xml 120 124 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Quintana1">[26]</xref>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Glant2">[27]</xref>
###xml 360 364 360 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Hanyecz1">[18]</xref>
###xml 104 108 <span type="species:ncbi:10116">rats</span>
###xml 145 148 <span type="species:ncbi:10116">rat</span>
###xml 161 166 <span type="species:ncbi:10090">mouse</span>
###xml 356 359 <span type="species:ncbi:31658">CFA</span>
###xml 465 468 <span type="species:ncbi:31658">CFA</span>
The immuno-regulatory effect of HSP70 immunization has been demonstrated earlier in arthritis models in rats [9], [25], [26]. In contrast to the rat models, the mouse PGIA model is a chronic and progressive model of RA [27]. In addition, in this model arthritis can be induced by immunization with proteoglycan mixed with synthetic adjuvant DDA instead of CFA [18]. Therefore, the possibility of interfering immune responses induced by mycobacterial HSP present in CFA can be excluded.
###end p 55
###begin p 56
###xml 173 181 169 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 523 524 519 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 693 697 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Haug1">[28]</xref>
###xml 980 984 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Mekala1">[29]</xref>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
In the present study an HSP70-specific T cell response was induced upon HSP70 immunization as detected by increased proliferation, IL-10 and IFN-gamma production upon HSP70 in vitro restimulation. Remarkably, also an enhanced PG-specific T cell response, with a similar cytokine profile, was found in HSP70 immunized mice. This might be explained by HSP70 interaction with innate receptors on antigen presenting cells, resulting in enhanced antigen priming to the subsequent PG immunization. Similarly, peptide-specific CD4+ T cell proliferation has been described to be enhanced when immunogenic peptides were fused to HSP70 subsequently resulting in increased immunogenicity of the peptides [28]. Alternatively, HSP70-induced regulatory T cells might induce a tolerogenic micro-milieu, by their cytokine production, enhancing the induction of regulatory T cells via infectious tolerance. This has been shown to occur in other models of autoimmunity in an IL-10 dependent manner [29].
###end p 56
###begin p 57
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Roncarolo1">[30]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Roncarolo2">[31]</xref>
###xml 495 496 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 500 501 500 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 643 644 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1002 1005 1002 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-vanPuijvelde1">[4]</xref>
###xml 1040 1041 1040 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1045 1046 1045 1046 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 529 533 <span type="species:ncbi:10090">mice</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 974 979 <span type="species:ncbi:10090">mouse</span>
###xml 1076 1080 <span type="species:ncbi:10090">mice</span>
Our data show that Hsp70 immunization induces a population of IL-10 producing T cells that do not express enhanced levels of Foxp3. Besides Foxp3 expressing CD25+ T cells, additional regulatory T cell subsets, such as adaptive Tr1, that do not express high levels of Foxp3 constitutively, are known [30]. Tr1 cells are induced in the periphery upon encounter of antigen and express high levels of IL-10 [31]. The HSP70-specifc IL-10 production together with enhanced IL-10 mRNA expression in CD4+CD25+ T cells in HSP70 immunized mice suggests activation or induction of HSP70-specific regulatory T cells. However, our observation that also CD3- cells produce enhanced levels of IL-10 in HSP70 immunized mice (data not shown) indicates that multiple subsets of regulatory cells can contribute to regulation and this remains to be elucidated. This is in contrast to a recent study, where we showed an increase in Foxp3 expressing regulatory T cells, after HSP treatment, in a mouse atherosclerosis model [4]. However, in the present study CD4+CD25+ T cells from HSP70 immunized mice did not increasingly express Foxp3, indicating the possible presence of distinct types of regulation in different models of inflammation.
###end p 57
###begin p 58
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Edwards1">[32]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Glant1">[17]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-ONeill1">[33]</xref>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Kaplan1">[34]</xref>
###xml 1194 1198 1194 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Kim1">[21]</xref>
###xml 1200 1204 1200 1204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Ulmansky1">[22]</xref>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 1189 1193 <span type="species:ncbi:10116">rats</span>
###xml 1290 1294 <span type="species:ncbi:10090">mice</span>
B cell responses play an important role in the pathogeneses of RA as demonstrated by the success of B cell targeted therapy, for example with monoclonal antibodies like Rituximab, as recently summarized [32]. Also in the PGIA model, B cells are important for disease induction [17], [33]. Therefore, the effect of HSP70 immunization on the B cell response was addressed by measuring PG-specific IgG1 and IgG2a production. Interestingly, decreased PG-specific IgG2a production was found in HSP70 immunized mice, while the IgG1 levels were not significantly changed. In earlier studies the IgG1 isotype has been shown to be the dominant isotype in the PGIA model. However, in agreement with our data, IgG2a levels have been described to correlate with disease severity [34]. Furthermore, the IgG2a isotype is known to be Th1 related. In accordance with these findings PGIA is considered to be a Th1 mediated model. Thus our data indicate that the pathogenic Th1 mediated PG-specific antibody response was inhibited by HSP70 immunization. In contrast to the arthritis associated PG-specific antibody response, HSP-specific antibodies have been shown to suppress adjuvant induced arthritis in rats [21], [22]. Therefore, the increased HSP70 IgG production found in our study in HSP70 immunized mice might be important for the regulatory potential of HSP70 treatment.
###end p 58
###begin p 59
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Guichelaar1">[35]</xref>
###xml 928 932 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-vanRoon1">[14]</xref>
###xml 1006 1010 1006 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Verhoef1">[36]</xref>
###xml 60 62 <span type="species:ncbi:10090">WT</span>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 307 309 <span type="species:ncbi:10090">WT</span>
###xml 310 314 <span type="species:ncbi:10090">mice</span>
###xml 1073 1078 <span type="species:ncbi:9606">human</span>
The increased HSP70-specifc B and T cell response, found in WT mice after HSP70 immunization, was also found in IL-10-/- mice. However, in the absence of IL-10 this response failed to suppress the pathogenic PG-specific B cell response and it did not increase the PG-specific T cell response as observed in WT mice. So, despite the induction of an obvious HSP70-specific response, the protective effects of HSP70 immunization on the PG-specific B and T cell response were shown to be IL-10 dependent, consequently leading to development of severe arthritis in the absence of IL-10. The important role of IL-10 in arthritis has been studied previously in the PGIA model. In this study transfer of cells expressing IL-10 after retroviral IL-10 gene transduction could suppress arthritis [35]. Moreover, IL-10 has been described to stimulate PG synthesis and to reverse cartilage degradation induced by activated mononuclear cells [14] and it negatively correlated with progression of joint destruction in RA [36], showing the important anti-inflammatory function of IL-10 in human RA.
###end p 59
###begin p 60
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-DeGraeffMeeder1">[37]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Boog1">[39]</xref>
###xml 416 419 416 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-deKleer1">[5]</xref>
###xml 421 424 421 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Kamphuis1">[6]</xref>
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Corrigall1">[40]</xref>
###xml 566 569 566 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-deKleer1">[5]</xref>
###xml 571 574 571 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004186-Kamphuis1">[6]</xref>
###xml 387 395 <span type="species:ncbi:9606">patients</span>
###xml 772 780 <span type="species:ncbi:9606">patients</span>
Due to their stress inducible nature HSP can be ideal candidates for immunotherapy against chronic inflammatory diseases like RA. HSP will be upregulated, locally at the site of inflammation in the joint, as reported previously [37]-[39]. Therefore, HSP-specific immune responses can be targeted specifically to sites of inflammation. Moreover, enhanced HSP-specific T cell responses in patients have been described [5], [6], [40]. The observation that such responses seemed to be associated with a benign form of disease, which over time preceded disease remission [5], [6], and the fact that HSP-mediated preventive and therapeutic immune interventions were effective in animal models of chronic inflammatory diseases, suggests the immunotherapeutic potential of HSP in patients with inflammatory autoimmune diseases.
###end p 60
###begin p 61
###xml 366 369 366 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
In summary, this study shows that HSP70 can modulate inflammation in a model for chronic and progressive arthritis through IL-10 dependent mechanisms, operating via suppression of pathogenic antibody responses and the development of regulatory T cells. The chronic and progressive nature of the model and the possibility to use specific knock out mice, like the IL10-/- used in this study, will enable further mechanistic studies needed for the development of HSP based immune intervention in chronic inflammatory diseases.
###end p 61
###begin p 62
The authors thank Elles Klein Koerkamp (Institute of Infectious Diseases and Immunology, Division of Immunology, Utrecht University, Utrecht, the Netherlands) and Anita Hanyecz (Department of Orthopedic Surgery, Rush University Medical Center, Chicago, IL 60612) for technical assistance. In addition, Prof. Dr. Berent Prakken (Department of Pediatric Immunology, University Medical Center Utrecht, Utrecht, the Netherlands) and the late Dr. Chris Broeren (Institute of Infectious Diseases and Immunology, Division of Immunology, Utrecht University, Utrecht, the Netherlands) for advise. Dr. Albert Marsman and colleagues of the hospital Hilversum (Hilversum, the Netherlands) and Dr. Floris Lafeber and colleagues (University Medical Center Utrecht, Utrecht, the Netherlands) for their help in obtaining essential materials.
###end p 62
###begin title 63
References
###end title 63
###begin article-title 64
Heat-shock proteins induce T-cell regulation of chronic inflammation.
###end article-title 64
###begin article-title 65
Stress, Heat Shock Proteins, and Autoimmunity: How immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases.
###end article-title 65
###begin article-title 66
Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies.
###end article-title 66
###begin article-title 67
Induction of Oral Tolerance to HSP60 or an HSP60-Peptide Activates T Cell Regulation and Reduces Atherosclerosis.
###end article-title 67
###begin article-title 68
###xml 105 110 <span type="species:ncbi:9606">human</span>
The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10.
###end article-title 68
###begin article-title 69
Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis.
###end article-title 69
###begin article-title 70
Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins.
###end article-title 70
###begin article-title 71
T cell responses to conserved bacterial heat-shock-protein epitopes induce resistance in experimental autoimmunity.
###end article-title 71
###begin article-title 72
A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue.
###end article-title 72
###begin article-title 73
###xml 90 93 <span type="species:ncbi:10116">rat</span>
Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis.
###end article-title 73
###begin article-title 74
Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis.
###end article-title 74
###begin article-title 75
Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial.
###end article-title 75
###begin article-title 76
Interleukin-10 and the interleukin-10 receptor.
###end article-title 76
###begin article-title 77
Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4.
###end article-title 77
###begin article-title 78
Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
###end article-title 78
###begin article-title 79
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.
###end article-title 79
###begin article-title 80
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics.
###end article-title 80
###begin article-title 81
Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype.
###end article-title 81
###begin article-title 82
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Interleukin-10-deficient mice develop chronic enterocolitis.
###end article-title 82
###begin article-title 83
###xml 86 101 <span type="species:ncbi:10090">transgenic mice</span>
Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
###end article-title 83
###begin article-title 84
Antibody responses to mycobacterial and self heat shock protein 65 in autoimmune arthritis: epitope specificity and implication in pathogenesis.
###end article-title 84
###begin article-title 85
Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion.
###end article-title 85
###begin article-title 86
###xml 107 115 <span type="species:ncbi:9606">patients</span>
Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis.
###end article-title 86
###begin article-title 87
Immune regulation in adjuvant-induced arthritis: possible implications for innovative therapeutic strategies in arthritis.
###end article-title 87
###begin article-title 88
###xml 38 64 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 104 107 <span type="species:ncbi:10116">rat</span>
A 71-kD heat shock protein (hsp) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis.
###end article-title 88
###begin article-title 89
###xml 88 93 <span type="species:ncbi:9606">human</span>
Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein.
###end article-title 89
###begin article-title 90
###xml 43 49 <span type="species:ncbi:10090">murine</span>
Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
###end article-title 90
###begin article-title 91
###xml 72 77 <span type="species:ncbi:9606">human</span>
The heat shock protein Hsp70 enhances antigen-specific proliferation of human CD4+ memory T cells.
###end article-title 91
###begin article-title 92
IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes.
###end article-title 92
###begin article-title 93
###xml 66 72 <span type="species:ncbi:9606">humans</span>
Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.
###end article-title 93
###begin article-title 94
###xml 32 37 <span type="species:ncbi:9606">human</span>
Is FOXP3 a bona fide marker for human regulatory T cells?
###end article-title 94
###begin article-title 95
B-cell targeting in rheumatoid arthritis and other autoimmune diseases.
###end article-title 95
###begin article-title 96
Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis.
###end article-title 96
###begin article-title 97
Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis.
###end article-title 97
###begin article-title 98
Autoantigen-specific IL-10-transduced T cells suppress chronic arthritis by promoting the endogenous regulatory IL-10 response.
###end article-title 98
###begin article-title 99
Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
###end article-title 99
###begin article-title 100
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis.
###end article-title 100
###begin article-title 101
Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs.
###end article-title 101
###begin article-title 102
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis.
###end article-title 102
###begin article-title 103
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis.
###end article-title 103
###begin p 104
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 104
###begin p 105
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants of the Dutch Arthritis Association, "Reumafonds" and SenterNovem, IOP Genomics project nr IGE03018, the European Union FP7 TOLERAGE: HEALTH-F4-2008-202156. Funders were not involved in design and conduct of the study, collection analysis and interpretation of the data or in the preperation, review or approval of the manuscript.
###end p 105

